ArticleJournal of thoracic disease2019

Recombinant human thrombopoietin combined with interleukin-2 improves the effects of chemosensitivity and thrombocytopenia on a basic gemcitabine and carboplatin combination therapy for non-small cell lung cancer in a nude mouse model.

Yunhua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.